EFFECT OF MEQUITAZINE ON THE PHARMACOKINETICS OF THEOPHYLLINE IN ASTHMATIC-PATIENTS

被引：6
|
作者：
HASEGAWA, T [1 ]
TAKAGI, K [1 ]
KUZUYA, T [1 ]
NADAI, M [1 ]
APICHARTPICHEAN, R [1 ]
MURAOKA, I [1 ]
机构：
[1] NAGOYA UNIV,SCH MED,DEPT INTERNAL MED 2,NAGOYA,AICHI 466,JAPAN
来源：
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 1990年 / 38卷 / 03期
关键词：
asthma; drug interaction; mequitazine; pharmacokinetics; theophylline;
D O I：
10.1007/BF00315026
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
The effect of an oral anti-allergic drug, mequitazine, on the pharmacokinetics of theophylline has been investigated in seven asthmatic patients. They received chronic theophylline therapy (a sustained-release theophylline tablet 200-400 mg b.d. at 12 h intervals) and coadministered mequitazine 6 mg for 3 weeks. Plasma theophylline concentration-time curves and the urinary excretion of theophylline and its major metabolites before and after coadministration of mequitazine were compared. No significant change in the pharmacokinetic parameters of theophylline or in the urinary recovery of unchanged drug and its metabolites was observed. Thus, mequitazine did not influence the pharmacokinetics of theophylline and it should be safe for coadministration to asthmatic patients on chronic theophylline therapy. © 1990 Springer-Verlag.
引用
收藏
页码：255 / 258
页数：4
相关论文
共 50 条
12345